US stock indices show divergent trends, AstraZeneca down nearly 5%

On April 9, after the US stock market opened, the three major indices displayed a divergent trend. The Dow Jones Industrial Average opened down 0.79%, indicating some downward pressure; the S&P 500 index also slightly declined by 0.4%, reflecting the overall cautious sentiment in the market; while the Nasdaq index rose against the trend, with an increase of 0.12%, showcasing the resilience of the tech sector.

Among the industry sectors, the performance of pharmaceutical companies is particularly noteworthy. AstraZeneca (AZN.O) saw its stock price continue to decline after the opening, with a drop of 4.7%. According to Tiger International data, as of 2025-04-09 09:34:48 (Eastern Time), its stock price was $61.44, down $3.46 from yesterday, representing a decline of 5.33%, with a total market capitalization of $190.539 billion. Similarly, GlaxoSmithKline (GSK.N) also performed poorly, with a decline of over 4%. The drop in pharmaceutical stock prices may be related to industry dynamics, policy changes, or factors such as the company's own research and sales, which are worth continued attention.